Article
Examination of the contribution of Nav1.7 to axonal propagation in nociceptors
2021-03-12
Abstract excerpt
Nav1.7 is a promising drug target for the treatment of pain because individuals with Nav1.7 loss-of-function mutations are insensitive to pain and do not have other serious neurological deficits. However, current peripherally restricted Nav1.7 inhibitors have not performed well in clinical pain trials, which may reflect a lack of understanding of the function of Nav1.7 in the transmission of nociceptive informatio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6dc04013-8339-5c26-9a78-4d18e30152c2
- DOI
- 10.1101/2021.03.12.435114
